Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond F Anton

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Alcohol Health and Research World|December 5, 2019
Medications for Treating AlcoholismRaymond F Anton
Addiction (Abingdon, England)|September 17, 2013
Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE StudyRaymond F Anton
Alcohol Health and Research World|December 5, 2019
Disulfiram Treatment of AlcoholismRaymond F Anton
Pharmacogenomics|June 4, 2008
Genetic basis for predicting response to naltrexone in the treatment of alcohol dependenceRaymond F Anton
Alcoholism, Clinical and Experimental Research|April 9, 2010
Editorial commentary: alcohol biomarker papersRaymond F Anton
Alcoholism, Clinical and Experimental Research|June 26, 2014
Commentary on: ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trialsRaymond F Anton
The New England Journal of Medicine|August 16, 2008
Naltrexone for the management of alcohol dependenceRaymond F Anton
JAMA Internal Medicine|July 18, 2020
Changed Primary Outcome Between Trial Registration and Publication-ReplyRaymond F Anton, Michaela Hoffman
Alcoholism, Clinical and Experimental Research|October 28, 2006
Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE StudyRaymond F Anton, Marston Youngblood
Addictive Behaviors|September 4, 2004
Biochemical alcohol screening in primary health carePeter M Miller, Raymond F Anton
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Alcohol Health and Research World|December 5, 2019
Medications for Treating AlcoholismRaymond F Anton
Addiction (Abingdon, England)|September 17, 2013
Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE StudyRaymond F Anton
Alcohol Health and Research World|December 5, 2019
Disulfiram Treatment of AlcoholismRaymond F Anton
Pharmacogenomics|June 4, 2008
Genetic basis for predicting response to naltrexone in the treatment of alcohol dependenceRaymond F Anton
Alcoholism, Clinical and Experimental Research|April 9, 2010
Editorial commentary: alcohol biomarker papersRaymond F Anton
Alcoholism, Clinical and Experimental Research|June 26, 2014
Commentary on: ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trialsRaymond F Anton
The New England Journal of Medicine|August 16, 2008
Naltrexone for the management of alcohol dependenceRaymond F Anton
JAMA Internal Medicine|July 18, 2020
Changed Primary Outcome Between Trial Registration and Publication-ReplyRaymond F Anton, Michaela Hoffman
Alcoholism, Clinical and Experimental Research|October 28, 2006
Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE StudyRaymond F Anton, Marston Youngblood
Addictive Behaviors|September 4, 2004
Biochemical alcohol screening in primary health carePeter M Miller, Raymond F Anton
Pageof 17